You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANTX Sale Disclosure
Readnour Robin Shane · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$31.86K
Readnour Robin Shane Director
ANTX
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
ANTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,294 shares @ $6.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-385511
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$97.32K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| An2 Therapeutics, Inc. ANTX | Sale | Sep 8, 2026 | $28.44K |
| An2 Therapeutics, Inc. ANTX Current | Sale | Sep 8, 2026 | $31.86K |
| An2 Therapeutics, Inc. ANTX | Sale | Sep 3, 2026 | $17.46K |
| An2 Therapeutics, Inc. ANTX | Sale | Sep 3, 2026 | $19.56K |